Solid Biosciences Inc.
SLDB
$3.29
-$0.01-0.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.17% | -30.52% | -3.16% | -19.51% | 3.07% |
| Total Depreciation and Amortization | 20.49% | -67.21% | 277.68% | 53.52% | -63.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 78.93% | 152.01% | 134.60% | -46.05% | 42.04% |
| Change in Net Operating Assets | -24.93% | 3,535.90% | 103.56% | 12.66% | -305.82% |
| Cash from Operations | -25.04% | -10.44% | 14.79% | -20.98% | -16.35% |
| Capital Expenditure | -1,260.00% | 94.76% | -91.95% | -65.56% | 76.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 453.32% | -124.38% | 87.25% | -184.48% | 287.14% |
| Cash from Investing | 451.02% | -112.27% | 86.55% | -184.97% | 283.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.67% | 46.67% | -- | -- | -- |
| Issuance of Common Stock | 109.36% | -38.74% | -95.08% | 22,091.29% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 94.07% | -- | -- |
| Cash from Financing | 113.14% | -34.88% | -95.34% | 21,135.84% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 150.45% | -45.26% | -149.69% | 74.39% | 158.73% |